Opinion: Malaria clinical research must include pregnant women Excluding pregnant women from clinical research puts them at greater risk of adverse effects in the real world due to the lack of evidence on how they can safely use medicines. On International Women’s Day, Medicines for Malaria Venture weighs in. 8 March 2024
Real-world effectiveness of single-dose tafenoquine for P. vivax relapse prevention confirmed in retrospective observational study in Brazil The Lancet Infectious Diseases published operational real-world effectiveness data confirming the public health and patient benefits of using quantitative G6PD testing and tafenoquine in P. vivax malaria case management in Brazil. 5 March 2024
Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study 3 March 2024 Lancet Infect Dis
Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysis 1 March 2024 Lancet Glob Health
Design and selection of drug properties to increase the public health impact of next-generation seasonal malaria chemoprevention: a modelling study 29 February 2024 Lancet Glob Health
Dreaming of a malaria free future: Protecting kids through SMC MMV's latest film shows malaria's impact on life in Tchaloudè, Togo. Driven by personal narratives from a mother, a village chief and a community health worker, the film highlights the challenges caused by malaria, particularly for children under 5. 28 February 2024
Safety and efficacy of pyronaridine-artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world study 27 February 2024 Malar J
Drug-induced stress mediates ring-stage growth arrest and reduces parasite susceptibility to artemisinin 15 February 2024 Microbiol Spectr
Oxidative stress changes the effectiveness of artemisinin in Plasmodium falciparum 6 February 2024 mBio
MMV delivers statements at the 154th session of the World Health Organization’s Executive Board MMV contributes to the Board’s debate on maternal and child health, antimalarial drug resistance, and climate change and health 29 January 2024
WHO Field guide: Community deployment of IPTp with sulfadoxine-pyrimethamine A new WHO field guide on community administration of intermittent preventive treatment of malaria in pregnancy (IPTp) to enable its integration into existing health systems. 25 January 2024
The European Lead Factory: Results from a decade of collaborative, public-private, drug discovery programs 17 January 2024 Drug Discov Today
Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial 11 January 2024 Lancet Infect Dis
First Ogobara K. Doumbo Scholarship Fund beneficiaries complete training In November 2023, the first beneficiaries of the Ogobara K. Doumbo Scholarship Fund completed a three-month internship at the Malaria Research and Training Center (MRTC) in Mali. 10 January 2024
A message from MMV's CEO, David Reddy: Standing united in the drive to eradicate malaria To quote the eminent Chinese scientist Dr. Tu Youyou: “Every scientist dreams of doing something that can help the world.” 14 December 2023
MAIP: An Open-Source Tool to Enrich High-Throughput Screening Output and Identify Novel, Druglike Molecules with Antimalarial Activity 13 December 2023 ACS Med Chem Lett
Tackling relapsing malaria in Thailand The ARCTIC study is a feasibility study in Thaliand to investigate the real-world use of quantitative point-of-care G6PD testing to determine appropriate relapse prevention treatment with tafenoquine or primaquine. 1 December 2023
World Malaria Report 2023: “We are at the crossroads of opportunities and challenges,” says WHO The report reveals some important global challenges, including climate change, as progress against the disease continues to stagnate. 30 November 2023
Africa-Europe partnership launches study to evaluate emergency response tools for severe malaria in highly isolated rural settings Africa-Europe partnership launches study to evaluate emergency response tools for severe malaria in highly isolated rural settings. 27 November 2023
MMV congratulates Professor David Fidock, new President-Elect of ASTMH MMV is delighted to hear of Dr. David Fidock’s selection as President-Elect of The American Society of Tropical Medicine and Hygiene (ASTMH). 13 November 2023